I

Iovance Biotherapeutics

TIL-based T-cell therapies for solid tumors

Business Development Director, Sales

Field SalesConfirmed live in the last 24 hours
Full-timeRemote in USA$250k - $275k /yr

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 10 years of pharmaceutical, biotechnology, specialty, or oncology sales experience, including at least 3 years in a senior account leadership role such as key account, strategic account, or regional business leadership.
  • Proven executive-level account management and consultative selling skills in oncology or another complex specialty area.
  • Ability to build credibility and influence senior clinical, operational, and business leaders.
  • Strong strategic thinking and business planning skills, including setting priorities and using resources wisely across a large geography.
  • Ability to lead and influence cross-functional partners without direct authority.
  • Communication, presentation, negotiation, and active listening skills.
  • Ability to analyze data, identify account and market trends, and turn insights into clear actions and recommendations.
  • Ability to use sound judgment in a fast-paced, evolving commercial environment where direction may not be fully defined.
  • Ability to collaborate across field and home-office teams.
  • Professionalism, judgment, integrity, and compliance awareness.
  • Demonstrated success exceeding sales goals, leading complex accounts, and influencing cross-functional teams and senior stakeholders.
  • Ability to travel frequently across the assigned territory, including overnight travel, customer meetings, and company events.
  • Valid driver's license and ability to meet company travel and fleet requirements, if applicable.
  • In-depth knowledge of oncology care delivery, academic and community oncology account structures, and specialty treatment center operations.
  • Understanding of how health systems and treatment centers make decisions, including the roles of committees, executives, and clinical leaders.
  • Strong working knowledge of patient referral pathways, reimbursement processes, payer coverage, and access barriers.
  • Thorough understanding of compliant pharmaceutical and biotechnology sales practices.
  • Familiarity with customer relationship management systems, sales reporting tools, and business analytics.

Responsibilities

  • Develop and own a multi-year business plan for the assigned territory that supports national commercial strategy and sets priorities, goals, and resource needs.
  • Lead strategy for high-value oncology accounts, academic medical centers, health systems, and authorized treatment centers, deciding where to focus time and effort.
  • Build and maintain senior-level relationships with executives, department chairs, oncology and cell therapy program leaders, and other key decision makers.
  • Identify and pursue new business opportunities, including activating new treatment centers and expanding work with existing ones, to grow appropriate product utilization.
  • Monitor performance, account trends, referral patterns, and access barriers across the territory; adjust plans and report results, risks, and forecasts to the Vice President, US Sales.
  • Maintain timely documentation of account activity, opportunities, risks, and follow-up actions.
  • Educate senior customers on approved product information, treatment logistics, patient identification considerations, and the end-to-end cell therapy process in a compliant manner.
  • Partner with field reimbursement, market access, medical affairs, and patient services teams to resolve complex or escalated account-level access and operational barriers.
  • Guide account readiness by working with internal teams on onboarding, referral workflows, and treatment center operations.
  • Share customer insights and market dynamics with senior leaders to help shape national planning and priorities.
  • Apply knowledge of payer dynamics, reimbursement pathways, and site-of-care considerations in oncology and cell therapy when advising on account strategy.
  • Coordinate with the Vice President, US Sales, and the other Business Development Director to maintain a consistent national approach to key accounts, share best practices, and align priorities.
  • Lead cross-functional account planning with marketing, market access, medical affairs, patient services, trade, and operations teams, and influence their priorities to support account objectives.
  • Share expertise and coach field and home-office colleagues to improve execution and customer experience.
  • Represent the company at executive customer meetings, regional programs, and approved conferences or educational events.
  • Follow company policies, applicable laws, industry guidelines, and compliance standards in customer interactions and model compliant behavior.
  • Use business tools and data to plan, prioritize accounts, and measure progress against goals.
  • Perform miscellaneous duties as assigned.

Desired Qualifications

  • A degree in life sciences, nursing, business, marketing, or a related field is preferred; an MBA or other advanced degree is also preferred.
  • Oncology, hematology, immuno-oncology, cell therapy, or rare disease sales experience.
  • Experience launching or growing a specialty or oncology product.
  • Experience working with academic medical centers, large oncology practices, or authorized treatment centers.
  • Understanding of cell therapy, immuno-oncology, or other complex specialty treatment models.
  • A patient-focused mindset and commitment to helping appropriate patients access innovative oncology treatments.
  • Ability to navigate complex customer environments and engage senior leaders with confidence and professionalism.
  • Strong ownership, follow-through, and adaptability in a growing organization, with willingness to help shape a new role.
  • Comfort learning scientific and operational details related to personalized cell therapy.
  • Ability to represent the company's mission and values in customer and team interactions.

About the Company

Iovance Biotherapeutics

TIL-based T-cell therapies for solid tumors

Iovance Biotherapeutics develops cancer immunotherapies using Tumor Infiltrating Lymphocytes (TIL). It harvests T cells from a patient’s tumor, expands them in the lab, and infuses them back into the patient to attack solid tumors. The therapies are designed as single-treatment treatments without the need for ongoing maintenance. The company differentiates itself by focusing on TIL-based adoptive cell therapy with broad antigen targeting and dedicated cell therapy manufacturing capabilities, including the Iovance Cell Therapy Center (iCTC) to scale production. Its goal is to develop, manufacture, and commercialize proprietary TIL therapies and expand access to cell-based cancer treatments through partnerships and scaled production.

Company size
501-1,000
Company stage
IPO
Headquarters
San Carlos, CA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Iovance Biotherapeutics

See more jobs